Bardavon bid to revolutionize workers’ compensation just got a $15 million boost
November 17, 2018 | Startland News Staff
Timing is everything, said Matt Condon, announcing this week $15 million in new financing to help scale his Overland Park-based company’s reach into markets from coast to coast.
“Our national expansion is coming at a time when employers across the country are recognizing that they must play a lead role in the transformation of health care,” said Condon, founder and CEO of Bardavon Health Innovations.
Bardavon’s physical medicine clinical analytics platform for workers’ compensation already is active in 21 states, according to the company, which was named one of Startland’s Top Kansas City Startups to Watch in 2018. Click here to learn more about why Bardavon was selected.
The four-year-old company’s latest expansion push comes thanks to $15 million in new funding led by NewRoad Capital Partners, based in Northwest Arkansas, which saw proven success in the venture-backed, cloud-based clinical intelligence and analytics of Bardavon, Condon said.
“This investment confirms that change is coming to health care, that workers’ compensation programs will help catalyze the transformation to quality-based medicine, and that Bardavon is well-positioned to lead that charge,” he said.
Health care cost containment strategies of the past simply have not worked, added Paul Morris, COO of Bardavon.
“We spend more each year on health care yet are less satisfied with the experience and outcome. Bardavon is changing that,” he said. “Our data-driven solutions and clinical expertise optimize care for each injured worker, enable the provider community to compete on quality, and improve the productivity of the workforce for our employers.”
The Overland Park firm — among the portfolio companies of the KCRise Fund, which has now invested more than $6 million across more than a dozen scaling Kansas City ventures — is poised for explosive growth, said Clete Brewer, managing partner of NewRoad Capital Partners in Rogers, Arkansas.
“Having followed Bardavon’s progress for three years and observed the breakthrough results in quality outcomes they have achieved with national employers, we are excited to be the lead investor that fuels their national expansion,” Brewer said.
Featured Business

2018 Startups to Watch
stats here
Related Posts on Startland News
Smart dog crate created in KC could be just months away; Interplay set for August crowdfunding, launch party
Dog owners are one step closer to getting their hands on the world’s first interactive dog crate as Kansas City-based Interplay plans the Aug. 12 launch of its hotly anticipated debut product, PlayTach. The milestone has been a long time coming, said Jonaie Johnson, founder and CEO of Interplay, who has been working on it…
‘If you don’t own yourself, you own nothing’: Why one founder says he’ll relocate his business if Kansas bans abortion
Editor’s note: This story is part of a series on the 2022 election produced by the KC Media Collective, an initiative designed to support and enhance local journalism. Members of the KC Media Collective include Startland News, Missouri Business Alert, Kansas City PBS/Flatland, KCUR, The Kansas City Beacon and American Public Square. Andrew Morgans has…
Shop Local KC gets minimalist makeover as local maker retailer opens Leawood store
Katie Mabry van Dieren is no stranger to the Ranch Mart Shopping Center in Leawood, the Shop Local KC owner said, returning to her roots this weekend to open a second location for her Kansas City maker retail store. “One of my greatest childhood memories was riding my bike to Ranch Mart and either getting…
KC wants to be the nation’s most equitable hub for biologics; prestigious MIT pick could help
Biologics is the entryway to personalized medicine, said Sonia Hall, and Kansas City is aiming to create the most inclusive hub for the development, production and distribution of biologics as part of its acceptance to the Massachusetts Institute of Technology Regional Entrepreneurship Acceleration Program. “When you talk about personalized medicine, you’re talking about greater equity…
